You can buy or sell NITE and other stocks, options, ETFs, and crypto commission-free!
Nightstar Therapeutics plc American Depositary Shares, also called Nightstar Therapeutics, is a clinical-stage gene therapy holding company, which engages in the development and commercialization of novel one-time treatments for patients suffering from rare inherited retinal diseases. Its pipeline includes NSR-REP1, for the treatment of choroideremia; NSR-RPGR, for the treatment of X-linked retinitis pigmentosa; and NSR-BEST1, for the treatment of vitelliform macular dystrophy. Read More The company was founded by Robert MacLaren on July 6, 2017 and is headquartered in London, the United Kingdom.
London, Greater London
52 Week High
52 Week Low
Seeking AlphaMar 12
Biogen Is Next In Line With Purchase Of Gene Therapy Biotech
There has been a massive increase this year for either acquisitions or partnerships being formed with gene therapy companies, with the likelihood that more deals are likely on the way.
Stock Price, News, & Analysis for Nightstar Therapeutics
Nightstar Therapeutics plc, a clinical-stage gene therapy company, focuses on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases in the United Kingdom.